Main Content

S E R V I C E S

Advisory Practice

Destum Partners has completed 40+ transactions worth over $5.25B. Our ability to optimize deal completion is due to our industry relationships, diverse scientific and business expertise, value driven processes, and our seasoned transaction team.

Consulting Practice

Consulting services allow companies to effectively achieve a variety of goals, ranging from enhanced corporate growth to developing a transaction strategy. We inform decision making to guide executives as they strive to create value.

Recent Transactions

QUIVER/ANGELINI

EPILEPSY
R&D COLLABORATION

ACURASTEM/TAKEDA

CNS
Nucleic Acid Therapy
PRE-CLINICAL LICENSE

BIORCHESTRA/Confidential

CNS
Nucleic Acid Therapy
R&D Collaboration

ANTIOS/IRBM

HBV
SMALL MOLECULES
ACQUISITION

PAION/LA JOLLA

HOSPITAL
EUROPE
Approved

BeneVir/Janssen

Immuno – Oncology
World Wide
Pre-Clinical

Cutanea/MEDIMETRIKS

Dermatology
Commercial
World Wide

MEI/Helsinn

Oncology
Phase III
World Wide

Advaxis/Amgen

Oncology
Pre-Clinical
World Wide

P&G/Honeylab

Dermatology
Commercial
World Wide
See More Success

Recent Consulting Success

ABOUT US

Meet the Team

OUR CULTURE

Destum Partners was formed in 2006 to fill a void in the biopharmaceutical and life sciences services sector. There were few firms, if any, that through a consulting practice could generate actionable recommendations for value maximization and also execute on those recommendations through an advisory practice. Destum Partners offers a fully integrated and customized solution that delivers on companies’ consulting and transactional needs.

As a boutique advisory and consulting firm, we pride ourselves on a “Client-centric” philosophy. We are selective in the companies we bring into the Destum portfolio to ensure compatibility and a high likelihood of success.

Our clients push the boundaries of innovation to improve the quality of life of humanity, a value central to Destum Partners' operating philosophy.